SAN FRANCISCO, Dec. 18, 2017 (GLOBE NEWSWIRE) -- Zephyr Health, the leading Insights-as-a-Service solution provider for Life Sciences companies, today announced that Zephyr Illuminate™ has been selected as one of the Top Innovative Products of 2017 by PM360. As featured in PM360’s annual Innovation issue, Relationship Analytics, a new ground-breaking capability of Zephyr Illuminate, was recognized for its ability to help Biopharma companies unlock the value of customer relationship networks to improve commercial efforts.
Relationship Analytics is designed to put a physician’s network into medical and market context based on type, importance, and strength of relevant connections. The insights generated by Relationship Analytics bridge the gap between disparate data and actionable next steps for more effective stakeholder engagement and decision-making.
“We are honored by PM360’s industry recognition of Relationship Analytics,” said William King, Founder and Executive Chairman, Zephyr Health. “This award caps off a successful year for Zephyr Health, in which we broadened the capabilities of Zephyr Illuminate, expanded the mobile platform to iPhone, and welcomed new Top 50 Biopharma and Medical Device customers. We look forward to continuing this momentum in 2018 and bringing innovative products to Life Sciences companies that deliver a sustainable competitive edge.”
About Zephyr Health
Zephyr Health helps Life Sciences companies – pharmaceutical, biotech, medical device and diagnostics – engage the right physicians, accounts and institutions using insights from global health data. Zephyr Illuminate™ is a leading Insights-as-a-Service solution that integrates thousands of data sources to create precise and predictive insights. From pre-launch to product maturity, Life Sciences companies can make confident decisions faster with data-driven targeting and deep customer profiles.
Zephyr Health is a privately held company headquartered in San Francisco with offices in London, UK, and Pune, India. Zephyr Health is venture backed by Google Ventures, Kleiner Perkins Caufield & Byers and Icon Ventures. For more information, please visit: www.zephyrhealth.com.
Media Contact:
pr@zephyrhealth.com